Fixing healthcare in the US

The United States spends nearly double the OECD average on healthcare per capita, yet it ranks last among high-income nations in life expectancy and preventable deaths. This paradox is not a failure of medical science, but a triumph of misaligned incentives. We do not have a healthcare system; we have a disease-management industry that profits from volume rather than value. To fix US healthcare, we must transition from a transactional fee-for-service model to a systemic value-based care paradigm. ## The root of the crisis: Incentives and administrative bloat In the traditional fee-for-service model, hospitals and physicians are compensated for the sheer volume of tests, procedures, and bed-nights they generate. This economic design naturally inflates costs. In his seminal paper [Who Pays for Health Care?](https://www.jstor.org/stable/2117822), economist Victor Fuchs argues that technological progress in medicine often drives costs upward because our financing structures lack the market mechanisms to demand efficiency. Furthermore, the administrative overhead required to navigate the fragmented multi-payer system is staggering. Research published in the [New England Journal of Medicine](https://www.nejm.org/doi/full/10.1056/NEJMsa1906387) by David Himmelstein and colleagues reveals that administrative costs consume over 30% of total US healthcare spending. This is money diverted directly from patient care to billing, coding, and insurance denial management. ## The path forward: Value, transparency, and primary care A structural overhaul must focus on three pillars: 1. **Global capitation and value-based payment**: Instead of paying for individual services, payers should transition to capitated models where providers receive a fixed budget to manage a patient's overall health. As Michael Porter and Elizabeth Teisberg argue in [Redefining Health Care](https://www.hbs.edu/faculty/Pages/item.aspx?num=18335): > "Value in health care is measured by the outcomes achieved, not the volume of services delivered... Coordinated, integrated care delivery around the patient’s medical condition is the only way to achieve dramatic improvements in value." 2. **Universal primary care access**: Investing in robust primary care reduces downstream emergency room visits and chronic disease complications. By decoupling primary care from insurance networks—such as through Direct Primary Care models—we can lower costs and rebuild the physician-patient relationship. 3. **Democratizing price and outcome data**: True consumer choice requires radical price transparency. Federal rules mandating hospitals to publish payer-negotiated rates must be strictly enforced to allow market competition to drive down prices for elective procedures. ## Further exploration To deepen this investigation, consider these critical inquiries: 1. **The role of artificial intelligence**: Can generative AI and automated clinical documentation eliminate the 30% administrative waste, or will it merely automate and accelerate insurance denial loops? 2. **The social determinants of health (SDOH)**: Since clinical care dictates only about 20% of health outcomes, should US healthcare dollars be legally reallocated to address housing insecurity, nutritional deserts, and environmental factors? 3. **The intellectual property bottleneck**: How can we reform the pharmaceutical patent system to lower drug prices without stifling the clinical innovation that produces life-saving therapies?